Evidence map›Paper›PMID 11559787›Full record

ArticleJournal of virology2001

Assembly and catalysis of concerted two-end integration events by Moloney murine leukemia virus integrase.

F Yang, M J Roth

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. BET proteins promote efficient murine leukemia virus integration at transcription start sites.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

F YangDepartment of Biochemistry, University of Medicine and Dentistry of New Jersey-- Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
M J Roth

Funding

MECHANISM OF RETROVIRAL INTEGRATIONR01CA076545 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROTH, MONICA J · 1998 to 2000
$242k
NCI NIH HHS R01 CA76545
6 · The paper itself

Abstract

Retroviral integration results in the stable and coordinated insertion of the two termini of the linear viral DNA into the host genome. An in vitro concerted two-end integration reaction catalyzed by the Moloney murine leukemia virus (M-MuLV) integrase (IN) was used to investigate the binding and coordination of the two viral DNA ends. Comparison of the two-end integration and strand transfer assays indicates that zinc is required for efficient concerted integration utilizing plasmid DNA as target. Complementation assays using a pair of nonoverlapping integrase domains, consisting of the HHCC domain and the core/C-terminal region, yielded products containing the correct 4-base target site duplication. The efficiency of the coordinated two-end integration varied depending on the order of addition of the individual protein and DNA components in the complementation assay. Two-end integration was most efficient when the long terminal repeat (LTR) was premixed with either the target DNA or the HHCC domain. The preference for two-end integration through preincubation of the HHCC finger with the viral DNA supports the role of this domain in the recognition and/or positioning of the LTR.

Indexed as

Virus IntegrationBinding SitesDNA, ViralIntegrasesMoloney murine leukemia virusOligonucleotidesPlasmidsProtein Structure, TertiaryRecombinant ProteinsTerminal Repeat SequencesZincZinc FingersDNA, ViralIntegrasesOligonucleotidesRecombinant ProteinsZinc

Identifiers

PMID11559787
PMCPMC114526
OpenAlexW2164479436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.